The IMA Group Acquires EVOnational, an IME Services Provider

Share Article

Latest acquisition adds 7,000 providers to IMA’s network and further expands its scope

Photo

Mark Weinberger, Ph.D., MPH, president of The IMA Group, today announced the company's acquisition of EVOnational.

"EVOnational brings our company the services, programs and people to ideally enhance and complement what we already offer our clients,” said IMA’s President Mark Weinberger, Ph.D., MPH

The IMA Group (IMA) announced today it has acquired EVOnational, a national provider of independent medical exams (IMEs), medical screenings and other evaluations. The acquisition extends IMA’s scope and capabilities while enhancing its national offering of behavioral and medical evaluations. The company serves the workers’ compensation, liability, disability and auto markets.

Financial terms of the acquisition for the two privately held companies were not disclosed. To ensure a seamless transition for existing clients, EVOnational will continue to operate under its current name, with key leadership, processes and staff remaining in place.

“EVOnational brings our company the services, programs and people to ideally enhance and complement what we already offer our clients,” said IMA’s President Mark Weinberger, Ph.D., MPH. “Their experience and commitment to their clients, emphasis on technology designed for our industry and excellent provider panel give us the ability to help clients tackle the tough challenges facing the industry today.”

The IMA Group is a technology-driven provider of medical and psychological evaluations and screening services, with more than 30 years’ experience in returning people to work and productivity. The acquisition adds more than 7,000 clinicians to its already robust provider panel and continues the company’s rapid pace of expansion. Through organic growth and acquisitions, The IMA Group’s provider panel has more than doubled its size in each of the past two years.

Both companies cite the value of the acquisition to clients as the further strengthening of the depth and breadth of IMA’s credentialed provider panel, providing more options for clients nationally, stated Doug Markham, IMA’s Chief Strategy Officer. “Additionally, EVOnational’s enhanced technology platform is intuitive and adjuster-focused, providing better visibility, transparency and ease of use, all of which helps facilitate more accurate and rapid resolution of claims while managing costs,” he added.

Seth Needelman, President of EVOnational, will continue to lead EVOnational under The IMA Group Payer Services division. He brings with him a team of seasoned industry experts and 30 years of IME experience.

“Both IMA and EVOnational share a passion for serving clients and delivering high-quality, defensible examinations that clients can rely on, no matter the claim,” said Needelman. “The combined experience of our two companies delivers proprietary organizational tools to ensure efficient time management and unprecedented cost savings. This will bring even greater value and benefits to our customers.”

For a full list of services and programs available through The IMA Group, visit https://www.theimagroup.com/iwhat-we-do/

Bailey Southwell & Co. served as the exclusive strategic and financial advisor to EVOnational on the transaction.

About The IMA Group:
For over 30 years, The IMA Group, headquartered in Tarrytown, New York and with offices nationwide, has been dedicated to helping people get back to work and resume productivity. Over the past 10 years, IMA has conducted more than three million evaluations nationwide, utilizing thousands of providers based both at IMA’s 90+ offices, as well as independent locations. We provide Government Services clients with medical, psychological and related evaluations, as well as ancillary services. Payer Services supports Commercial Insurers, TPAs and Corporate clients with Independent Medical Evaluations, and Occupational Health Services, Fitness for Duty determinations, Pre-Employment examinations and Forensic Drug Testing. The Clinical Research Division offers access to new advances in pharmacology and biotechnology for research subjects, as well as a robust database of interested participants for pharmaceutical manufacturers. For more information visit http://www.theIMAgroup.com.

Media Contact
Joy Scott
President & CEO, Scott Public Relations
818-610-0270
joy@scottpublicrelations.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brenna Harrington

Doug Markham
Visit website